Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Transcranial Temporal Interference Stimulation on Upper-Limb Motor Recovery in Early Subacute Ischemic Stroke: A Randomized, Double-Blind, Sham-Controlled Pilot Trial

NCT07896629 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07896629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Transcranial Temporal Interference Stimulation on Upper-Limb Motor Recovery in Early Subacute Ischemic Stroke: A Randomized, Double-Blind, Sham-Controlled Pilot Trial
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
February 29, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke

Arms

As registered; 2 arms.

  • Active tTIs Group ExperimentalTranscranial Temporal Interference Stimulation (tTIs)

    Participants will receive individualized active transcranial temporal interference stimulation targeting the cerebellar dentate nucleus contralateral to the cerebral lesion, 20 minutes per session, once daily for 20 consecutive days, combined with routine rehabilitation therapy.

  • Sham tTIs Group Sham comparatorSham Transcranial Temporal Interference Stimulation (Sham tTIs)

    Participants will receive sham transcranial temporal interference stimulation followed by the same standardized routine rehabilitation therapy. The sham procedure will use the same device, electrode montage, session duration, and ramp sensations as active stimulation but will not deliver sustained active stimulation.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Fugl-Meyer Assessment of Upper Extremity (FMA-UE) 20 days after the start of intervention

    Change in Fugl-Meyer Assessment of Upper Extremity score, range 0-66; higher score indicates better upper limb motor function.

Lead sponsor's other trials

Xuanwu Hospital, Beijing, most recent start first.

Similar trials

Same condition (Ischemic Stroke) and phase, most recent start first.